Considering the APOE locus in Alzheimer's disease polygenic scores in the Health and Retirement Study: a longitudinal panel study

被引:14
|
作者
Ware, Erin B. [1 ]
Faul, Jessica D. [1 ]
Mitchell, Colter M. [1 ]
Bakulski, Kelly M. [2 ]
机构
[1] Univ Michigan, Inst Social Res, Survey Res Ctr, 426 Thompson St,Rm 3320 ISR Thompson, Ann Arbor, MI 48104 USA
[2] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA
基金
美国国家卫生研究院;
关键词
Polygenic score; Alzheimer’ s disease; Dementia; Apolipoprotein E; P-value; Thresholding; GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E; RISK SCORE; VARIANTS; ARCHITECTURE; METAANALYSIS; TAU;
D O I
10.1186/s12920-020-00815-9
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Background Polygenic scores are a strategy to aggregate the small, additive effects of single nucleotide polymorphisms across the genome. With phenotypes like Alzheimer's disease, which have a strong and well-established genomic locus (APOE), the cumulative effect of genetic variants outside of this area has not been well established in a population-representative sample. Methods Here we examine the association between polygenic scores for Alzheimer's disease both with and without the APOE region (chr19: 45,384,477 to 45,432,606, build 37/hg 19) at different P value thresholds and dementia. We also investigate the addition of APOE-epsilon 4 carrier status and its effect on the polygenic score-dementia association in the Health and Retirement Study using generalized linear models accounting for repeated measures by individual and use a binomial distribution, logit link, and unstructured correlation structure. Results In a large sample of European ancestry participants of the Health and Retirement Study (n = 9872) with an average of 5.2 (standard deviation 1.8) visit spaced two years apart, we found that including the APOE region through weighted variants in a polygenic score was insufficient to capture the large amount of risk attributed to this region. We also found that a polygenic score with a P value threshold of 0.01 had the strongest association with the odds of dementia in this sample (odds ratio = 1.10 95%CI 1.0 to 1.2). Conclusion We recommend removing the APOE region from polygenic score calculation and treating the APOE locus as an independent covariate when modeling dementia. We also recommend using a moderately conservative P value threshold (e.g. 0.01) when creating polygenic scores for Alzheimer's disease on dementia. These recommendations may help elucidate relationships between polygenic scores and regions of strong significance for phenotypes similar to Alzheimer's disease.
引用
收藏
页数:13
相关论文
共 50 条
  • [1] Considering the APOE locus in Alzheimer’s disease polygenic scores in the Health and Retirement Study: a longitudinal panel study
    Erin B. Ware
    Jessica D. Faul
    Colter M. Mitchell
    Kelly M. Bakulski
    BMC Medical Genomics, 13
  • [2] Longitudinal dynamic analyses of cognition in the health and retirement study panel
    John J. McArdle
    AStA Advances in Statistical Analysis, 2011, 95 : 453 - 480
  • [3] Longitudinal dynamic analyses of cognition in the health and retirement study panel
    McArdle, John J.
    ASTA-ADVANCES IN STATISTICAL ANALYSIS, 2011, 95 (04) : 453 - 480
  • [4] Polygenic Risk Scores in Familial Alzheimer's Disease
    Tosto, Giuseppe
    Bird, Thomas D.
    Bennet, David A.
    Boeve, Bradley F.
    Brickman, Adam M.
    Cruchaga, Carlos
    Faber, Kelley
    Foroud, Tatiana M.
    Farlow, Martin
    Goate, Alison M.
    Graff-Radford, Neil R.
    Lantigua, Rafael
    Manly, Jennifer
    Ottman, Ruth
    Rosenberg, Roger
    Schaid, Daniel J.
    Schupf, Nicole
    Stern, Yaakov
    Sweet, Robert A.
    Mayeux, Richard
    ANNALS OF NEUROLOGY, 2016, 80 : S182 - S182
  • [5] Polygenic risk scores for Alzheimer's disease are related to dementia risk in APOE e4 negatives
    Najar, Jenna
    van der Lee, Sven J.
    Joas, Erik
    Wetterberg, Hanna
    Hardy, John
    Guerreiro, Rita
    Bras, Jose
    Waern, Margda
    Kern, Silke
    Zetterberg, Henrik
    Blennow, Kaj
    Skoog, Ingmar
    Zettergren, Anna
    ALZHEIMER'S & DEMENTIA: DIAGNOSIS, ASSESSMENT & DISEASE MONITORING, 2021, 13 (01)
  • [6] Polygenic risk and hazard scores for Alzheimer's disease prediction
    Leonenko, Ganna
    Sims, Rebecca
    Shoai, Maryam
    Frizzati, Aura
    Bossu, Paola
    Spalletta, Gianfranco
    Fox, Nick C.
    Williams, Julie
    Hardy, John
    Escott-Price, Valentina
    Tsolaki, Magda
    Craig, David
    Avramidou, Despoina
    Germanou, Antonia
    Koutroumani, Maria
    Gkatzima, Olymbia
    Hampel, Harald
    Kehoe, Patrick G.
    Love, Seth
    Rubinsztein, David C.
    Frolich, Lutz
    McGuinness, Bernadette
    Johnston, Janet A.
    Passmore, Peter
    Drichel, Dmitriy
    Rossor, Martin
    Schott, Jonathan M.
    Warren, Jason D.
    Bras, Jose
    Guerreiro, Rita
    Kawalia, Amit
    Hughes, Joseph T.
    Patel, Yogen
    Lupton, Michelle K.
    Proitsi, Petra
    Powell, John
    Kauwe, John S. K.
    Mancuso, Michelangelo
    Bonuccelli, Ubaldo
    Uphill, James
    Fisher, Elizabeth
    Masullo, Carlo
    Soininen, Hilkka
    Bisceglio, Gina
    Ma, Li
    Dickson, Dennis W.
    Graff-Radford, Neill R.
    Carrasquillo, Minerva M.
    Younkin, Steven G.
    Sorbi, Sandro
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2019, 6 (03): : 456 - 465
  • [7] Age -dependent effect of APOE and polygenic component on Alzheimer?s disease
    Bellou, Eftychia
    Baker, Emily
    Leonenko, Ganna
    Bracher-Smith, Matthew
    Daunt, Paula
    Menzies, Georgina
    Williams, Julie
    Escott-Price, Valentina
    NEUROBIOLOGY OF AGING, 2020, 93 : 69 - 77
  • [8] HARMONIZING COGNITIVE SCORES ACROSS WAVES IN THE CHINA HEALTH AND RETIREMENT LONGITUDINAL STUDY
    Wu, Yingyan
    Mayeda, Elizabeth Rose
    Kobayashi, Lindsay
    Gross, Alden
    Zhang, Yuan
    INNOVATION IN AGING, 2024, 8 : 636 - 636
  • [9] Alzheimer's polygenic risk scores, APOE, Alzheimer's disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years
    Stocker, Hannah
    Trares, Kira
    Beyer, Leon
    Perna, Laura
    Rujescu, Dan
    Holleczek, Bernd
    Beyreuther, Konrad
    Gerwert, Klaus
    Schoettker, Ben
    Brenner, Hermann
    ALZHEIMERS RESEARCH & THERAPY, 2023, 15 (01)
  • [10] Alzheimer’s polygenic risk scores, APOE, Alzheimer’s disease risk, and dementia-related blood biomarker levels in a population-based cohort study followed over 17 years
    Hannah Stocker
    Kira Trares
    Léon Beyer
    Laura Perna
    Dan Rujescu
    Bernd Holleczek
    Konrad Beyreuther
    Klaus Gerwert
    Ben Schöttker
    Hermann Brenner
    Alzheimer's Research & Therapy, 15